Evidence map›Paper›PMID 39767799›Full record

ArticleBiomedicines2024

Overlapping Systemic Proteins in COVID-19 and Lung Fibrosis Associated with Tissue Remodeling and Inflammation.

Barbora Svobodová, Anna Löfdahl, Annika Nybom, Jenny Wigén, Gabriel Hirdman, Franziska Olm, Hans Brunnström, Sandra Lindstedt, Gunilla Westergren-Thorsson, Linda Elowsson

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Barbora SvobodováLung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Anna LöfdahlLung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Annika NybomLung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Jenny WigénLung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.
Gabriel HirdmanDepartment of Cardiothoracic Surgery and Transplantation, Skåne University Hospital, 222 42 Lund, Sweden.
Franziska OlmDepartment of Cardiothoracic Surgery and Transplantation, Skåne University Hospital, 222 42 Lund, Sweden.ORCID 0000-0001-5222-6130
Hans BrunnströmDepartment of Clinical Sciences, Lund University, 221 84 Lund, Sweden.ORCID 0000-0001-7402-138X
Sandra LindstedtDepartment of Cardiothoracic Surgery and Transplantation, Skåne University Hospital, 222 42 Lund, Sweden.
Gunilla Westergren-ThorssonLung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.ORCID 0000-0001-5327-8805
Linda ElowssonLung Biology Unit, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.ORCID 0000-0002-0457-0188

Funding

Swedish Foundation for Strategic Research SBE13-0130Swedish Heart-Lung Foundation 20200330, 20210086, 20210289Swedish Research Council 2020-01375
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersCOVID-19DCNfibrosisHGFIPFMCP-3TNFRSF12A

Identifiers

PMID39767799
PMCPMC11727205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.